These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 19889173)
1. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Dovigo LN; Pavarina AC; Mima EG; Giampaolo ET; Vergani CE; Bagnato VS Mycoses; 2011 Mar; 54(2):123-30. PubMed ID: 19889173 [TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Candida biofilms to histatin 5 and fluconazole. Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans. De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140 [TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples]. Hüseyin A; Sancak B; Arikan S Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710 [TBL] [Abstract][Full Text] [Related]
6. Respiratory deficiency enhances the sensitivity of the pathogenic fungus Candida to photodynamic treatment. Chabrier-Roselló Y; Foster TH; Mitra S; Haidaris CG Photochem Photobiol; 2008; 84(5):1141-8. PubMed ID: 18248505 [TBL] [Abstract][Full Text] [Related]
7. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole. Bruzual I; Riggle P; Hadley S; Kumamoto CA J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564 [TBL] [Abstract][Full Text] [Related]
8. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans. Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969 [TBL] [Abstract][Full Text] [Related]
9. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Barton R; Bijie H; Bille J; Chang SC; da Luz Martins M; Duse A; Dzierzanowska D; Ellis D; Finquelievich J; Gould I; Gur D; Hoosen A; Lee K; Mallatova N; Mallie M; Peng NG; Petrikos G; Santiago A; Trupl J; VanDen Abeele AM; Wadula J; Zaidi M; Diagn Microbiol Infect Dis; 2010 Jun; 67(2):162-71. PubMed ID: 20338711 [TBL] [Abstract][Full Text] [Related]
10. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole]. Kurnatowski P; Makieło L; Horwatt-Bozyczko E Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440 [TBL] [Abstract][Full Text] [Related]
11. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study. Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780 [TBL] [Abstract][Full Text] [Related]
12. [Biofilm production and antifungal susceptibility patterns of Candida species]. Yücesoy M; Karaman M Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907 [TBL] [Abstract][Full Text] [Related]
14. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole. Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods. Guo N; Wu X; Yu L; Liu J; Meng R; Jin J; Lu H; Wang X; Yan S; Deng X FEMS Immunol Med Microbiol; 2010 Mar; 58(2):193-201. PubMed ID: 19878317 [TBL] [Abstract][Full Text] [Related]
16. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278 [TBL] [Abstract][Full Text] [Related]
17. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome. Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp. Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851 [TBL] [Abstract][Full Text] [Related]
19. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001]. Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191 [TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of fluconazole against Candida albicans isolated from blood culture]. Pemán J; Cantón E; Orero A; Ubeda P; Viudes A; Pastor A; Gobernado M Rev Esp Quimioter; 1998 Dec; 11(4):339-43. PubMed ID: 10336314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]